N3 HNSCC: outcomes poor despite treatment intensification
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Patients with N3 head and neck squamous cell carcinoma (HNSCC) treated with very accelerated radiotherapy (VART) or concurrent chemoradiotherapy (CCRT) had 5-y OS of 13.8%.
Why this matters
- Outcomes of N3 patients have not been widely reported.